Related Experiment Videos
Update on psoriasis therapy: a perspective from the USA.
1Department of Dermatology, University of California San Francisco Medical Center, USA.
The Keio Journal of Medicine
|April 6, 2000
Summary
Sharing experiences with new psoriasis treatments like calcipotriol, acitretin, and cyclosporine, along with sequential therapy, can help optimize patient care globally. International collaboration is key to maximizing the efficacy of these novel dermatological agents.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Recent approvals of novel psoriasis treatments in the US, including topical calcipotriol and systemic agents acitretin and cyclosporine.
- Introduction of a new therapeutic strategy: sequential therapy for psoriasis management.
Discussion:
- The international exchange of clinical experiences with new medications is crucial for enhancing global therapeutic efficacy.
- Physicians often adopt new drugs at different times, highlighting the need for shared insights.
Key Insights:
- Novel systemic and topical agents offer new avenues for psoriasis treatment.
- Sequential therapy represents a significant advancement in managing psoriasis.
- Sharing US-based experiences can inform international dermatologists on optimizing these treatments.
Outlook:
- Facilitating the exchange of treatment paradigms and experiences can improve psoriasis care worldwide.
- Empowering dermatologists, particularly in Japan, with insights into optimizing new psoriasis therapies.